Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Halozyme Therapeutic (HALO)

Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
HALO
The Top 5 Analyst Questions From Halozyme Therapeutics’s Q2 Earnings Call StockStory - Thu Aug 13, 12:41AM CDT

The Top 5 Analyst Questions From Halozyme Therapeutics’s Q2 Earnings Call

HALO : 101.79 (-0.81%)
HALO
HALO Q2 Deep Dive: Royalty Diversification and New Pipeline Drive Upgraded Guidance StockStory - Fri Aug 7, 5:20PM CDT

HALO Q2 Deep Dive: Royalty Diversification and New Pipeline Drive Upgraded Guidance

HALO : 101.79 (-0.81%)
HALO
Halozyme Therapeutics (HALO) Shares Skyrocket, What You Need To Know StockStory - Fri Aug 7, 4:35PM CDT

Halozyme Therapeutics (HALO) Shares Skyrocket, What You Need To Know

HALO : 101.79 (-0.81%)
MTN
1 Profitable Stock to Research Further and 2 We Ignore StockStory - Thu Aug 6, 11:40PM CDT

1 Profitable Stock to Research Further and 2 We Ignore

MTN : 148.36 (+0.47%)
TTI : 8.74 (-0.91%)
HALO : 101.79 (-0.81%)
HALO
Halozyme Therapeutics (NASDAQ:HALO) Beats Expectations in Strong Q2 CY2026, Guides for Strong Full-Year Sales StockStory - Thu Aug 6, 3:45PM CDT

Halozyme Therapeutics (NASDAQ:HALO) Beats Expectations in Strong Q2 CY2026, Guides for Strong Full-Year Sales

HALO : 101.79 (-0.81%)
Halozyme Therapeutics: Q2 Earnings Snapshot AP - Thu Aug 6, 3:08PM CDT

Halozyme Therapeutics: Q2 Earnings Snapshot

HALO : 101.79 (-0.81%)
Halozyme's Royalty Engine: Whether Guidance Holds Reveals True Durability of the Model Barchart - Wed Aug 5, 4:15PM CDT

Barchart Research What to Expect from HALO Earnings HALO Generated August 5, 2026 Current Price $83.59 EPS Estimate $$1.73 Consensus Rating Moderate Buy Average Move 7.08% Halozyme's Royalty Engine: Whether...

HALO : 101.79 (-0.81%)
HALO
What To Expect From Halozyme Therapeutics’s (HALO) Q2 Earnings StockStory - Tue Aug 4, 10:25PM CDT

What To Expect From Halozyme Therapeutics’s (HALO) Q2 Earnings

HALO : 101.79 (-0.81%)
RKLB
3 Growth Stocks Set to Flourish StockStory - Sun Aug 2, 11:31PM CDT

3 Growth Stocks Set to Flourish

HAPN : 19.49 (+1.35%)
RKLB : 81.17 (+1.45%)
HALO : 101.79 (-0.81%)
VNT
1 Cash-Producing Stock on Our Watchlist and 2 We Ignore StockStory - Thu Jul 23, 11:41PM CDT

1 Cash-Producing Stock on Our Watchlist and 2 We Ignore

EE : 35.75 (+1.10%)
VNT : 33.42 (-1.94%)
HALO : 101.79 (-0.81%)

Barchart Exclusives

The Calm Before the Storm? Low IV Stocks Worth Watching Barchart - 2 minutes ago
Market volatility has dropped since the recent correction, but with plenty of items on the news front, we could see a volatility spike at any point. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.